New formulations.
- Published in:
- Formulary, 2007, v. 42, n. 9, p. 521
- Publication type:
- Article
Works matching DE "CSL Behring LLC"
Results: 10
1
2
Safety without the wire.
- Published in:
- TCE: The Chemical Engineer, 2011, n. 843, p. 30
- By:
- Publication type:
- Article
3
ASCPT NEWS.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 4, p. 570, doi. 10.1002/cpt.796
- Publication type:
- Article
4
The COPD Pipeline II.
- Published in:
- COPD: Journal of Chronic Obstructive Pulmonary Disease, 2010, v. 7, n. 1, p. 76, doi. 10.3109/15412550903501244
- By:
- Publication type:
- Article
5
INCENTIVISING INNOVATION OR SUPPORTING OTHER INTERESTS? EUROPEAN REGULATION OF ORPHAN MEDICINAL PRODUCTS.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
6
New drugs and dosage forms.
- Published in:
- 2009
- Publication type:
- Product Review
7
FDA approves fibrinogen concentrate product.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 5, p. 428, doi. 10.2146/news090019
- By:
- Publication type:
- Article
8
News From the Food and Drug Administration.
- Published in:
- JAMA: Journal of the American Medical Association, 2016, v. 315, n. 15, p. 1555
- By:
- Publication type:
- Article
9
Plasma product companies outmuscle small recombinant players.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 10, p. 1060, doi. 10.1038/nbt1008-1060c
- By:
- Publication type:
- Article
10
Companies line up for hereditary angioedema market.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 4, p. 364, doi. 10.1038/nbt0408-364
- By:
- Publication type:
- Article